We describe two cases of human infections caused by Staphylococcus aureus clonal complex (CC) 75, also called Staphylococcus argenteus, harbouring the Panton-Valentine leucocidin (PVL). These two sporadic cases were community-acquired, and identified in France in 2014. Both had an epidemiological link with Mayotte, an overseas department of France located in the Indian Ocean off the south-eastern African coast. This report illustrates that, contrary to previous descriptions, S. argenteus can acquire important virulence factors and be responsible for severe infections.
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In 2014, two cases of human infections caused by Staphylococcus aureus isolates belonging to clonal complex (CC) 75 lineage, also called Staphylococcus argenteus, harbouring the Panton-Valentine leucocidin (PVL) occurred in France. The two cases were sporadic and community-acquired, and had an epidemiological link with Mayotte, a French archipelago in the Indian Ocean. The two strains affecting the respective cases were both isolated from blood culture.
Description Case 1
In January 2014, a French woman of Comorian origin in her mid-twenties presented to the Emergency Department of a hospital in Lyon, with an eight-day history of deterioration of the general condition, chills and cough complicated by haemoptysis starting the day before. The symptoms had appeared three weeks after the excision of a recurrent abscess in the left thigh for which the patient had initially received oral treatment with amoxicillin-clavulanic acid during five days, then roxithromycin during the following eight days. /L), a C-reactive protein (CRP) of 251 mg/L (norm: <3 mg/L), and abnormal liver function tests (alanine and aspartate transaminases, alkaline phosphatase and gammaglutamyl transpeptidase were all elevated). A chest radiography revealed a bilateral abscessed pneumonia with right pleural effusion. Blood cultures were immediately initiated but no pulmonary sample was taken prior to antibiotherapy at the hospital. Treatment was started with ceftriaxone-spiramycin on the same day. The next day, blood culture was positive with S. aureus. As the strain was susceptible to meticillin and positive for Panton-Valentine leucocidin (PVL) by polymerase chain reaction (PCR), treatment was changed to intravenous oxacillin and clindamycin per os. After initiation of this treatment, fever disappeared in only one day while haemoptysis persisted for seven days. No other pathogen was identified. After 21 days, treatment was stopped due to a drug rash with eosinophilia and systemic symptoms (DRESS) syndrome and replaced by linezolid up to a total duration of five weeks. S. aureus decolonisation was performed during hospitalisation to eradicate nasal carriage and to prevent recurrences.
Case 2
In November 2014, an 18-month-old child living in Mayotte presented at a dispensary with a three-day history of fever and right lower limb pain. They were referred to the hospital Emergency Department of Mamoudzou. At the time of admission, the clinical examination led to suspect arthritis of the right knee with a skin lesion in front and inflammatory extension to the rest of the leg. Body temperature was 39.8 °C and heart rate 193/min. Laboratory findings showed a white blood cell count of 13.4 x 10 9 /L and a CRP of 229 mg/L. Ultrasound revealed joint effusion which could not be punctured. Blood cultures were immediately collected and treatment started with amoxicillin-clavulanic acid and gentamicin intravenously. The next day, the child was transferred to the intensive care unit due to worsening tachycardia and cold extremities despite the infusion of a volume expander. Blood culture was positive with S. aureus susceptible to meticillin. Based on suspicion of a toxin-mediated infection, treatment was changed to clindamycin, gentamicin, linezolid and polyvalent immunoglobulins intravenously. Blood culture became negative 48 hours after the initiation of antibiotherapy. Three days after admission, ultrasound showed joint effusion of the right knee associated with a collection at the quadriceps bursa. Culture from pus aspiration yielded an S. aureus isolate susceptible to meticillin. The S. aureus isolate was positive for PVL by PCR. Treatment was continued intravenously with oxacillin and clindamycin. Multiple pulmonary abscesses appeared on the tenth day, which led to change treatment for clindamycin-rifampicin and finally for amoxicillin-clavulanic acid-rifampicin orally for a total of six weeks, allowing the patient's recovery.
Analysis of strains
Blood cultures from the two patients yielded S. aureus isolates, which were sent to the French national reference centre for staphylococci in Lyon for characterisation.
The two strains were identified by matrix-assisted laser desorption/ionization time-of-flight (Maldi-Tof) mass spectrometry as S. aureus. Antimicrobial susceptibility testing was performed by disk diffusion assay or on automated Vitek2 system and interpreted according to the 2013 guidelines of the Antibiogram Committee of the French Society for Microbiology (CA-SFM). The following panel of antibiotics was tested: penicillin, oxacillin or cefoxitin, kanamycin, tobramycin, gentamicin, erythromycin, clindamycin or lincomycin, pristinamycin, levofloxacin or ofloxacin, tetracycline, rifampicin, trimethoprim-sulfamethoxazole, fusidic acid, fosfomycin, linezolid, teicoplanin, and vancomycin. The two isolates were susceptible to meticillin and to all the antibiotics tested except penicillin.
Further characterisation of the strains with the DNA microarray Identibac S. aureus Genotyping (Alere Technologies, Jena, Germany) for staphylococcal cassette chromosome (SCC) mec typing and toxin profiling [1] revealed that the two strains harboured the PVL genes and belonged to the S. argenteus lineage sequence type (ST) 2250/2277. This was confirmed by PVL PCR and by assignment by multilocus sequence typing (MLST) to ST2250 using specific primers for aroE [2] . Alignment of the seven MLST gene sequences from the patients' respective strains to those of S. argenteus, and neighbour-joining phylogenetic analysis showed that the two strains belonged to the S. argenteus lineage. Moreover, after 48 hours of growth, the two strains presented a lack of pigmentation typical of S. argenteus [3] .
Discussion
This is, to the best of our knowledge, the first observation of S. argenteus lineage isolates harbouring the PVL genes. S. argenteus has recently been described as a novel species in the genus Staphylococcus, and is -as S. schweitzeri is -part of an S. aureus species complex [1] . Several studies previously described the CC75 lineage as grouping clones of S. aureus belonging to STs that are very distant from all other clones and characterised by the lack of staphyloxanthin (e.g. ST75, ST850, ST883, ST1223, ST1304, ST1850) [2] [3] [4] [5] . Such strains were isolated mainly from indigenous populations in Australia and French Guyana [2, 4, 6] , but also in Cambodia, Fiji, Trinidad and Tobago, Thailand [7] [8] [9] [10] and from animals in Africa [11, 12] . No strain harbouring the PVL was described among these isolates, which were considered as having an attenuated virulence compared with other S. aureus strains [5, 13, 14] .
By confering cytotoxicity on neutrophils and monocytes-macrophages, PVL leads to a high degree of virulence [15] . PVL-positive strains are most frequently responsible for skin and soft-tissue infections, but can also cause severe necrotising pneumonia or aggressive bone and joint infections [16] . The present results indicate that some strains belonging to the S. argenteus lineage are able to acquire the PVL phage. Moreover, the severity of the clinical presentation of the two cases described in this report strongly suggests an important role of PVL in their infections.
Both cases described had a link to Mayotte which indicates the potential geographical origin of these isolates there. Enhanced surveillance is therefore necessary to determine whether PVL-positive S. argenteus lineage might emerge as a cause of infections in Mayotte and might disseminate further in France and in other countries.
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